Clinical Trial Update: Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in China evaluated tiotropium for early chronic obstructive pulmonary disease to assess its safety and efficacy in this population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tiotropium (Spiriva) (tiotropium)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED